Lenalidomide monotherapy in relapsed or refractory aggressive non-Hodgkin's lymphoma.

Wiernik, Peter H; Lossos, Izidore S; Tuscano, Joseph M; Justice, Glen; Vose, Julie M; Cole, Craig E; Lam, Wendy; McBride, Kyle; Wride, Kenton; Pietronigro, Dennis; Takeshita, Kenichi; Ervin-Haynes, Annette; Zeldis, Jerome B; Habermann, Thomas M

Wiernik, Peter H; Lossos, Izidore S; Tuscano, Joseph M; Justice, Glen; Vose, Julie M; Cole, Craig E; Lam, Wendy; McBride, Kyle; Wride, Kenton; Pietronigro, Dennis; Takeshita, Kenichi; Ervin-Haynes, Annette; Zeldis, Jerome B; Habermann, Thomas M.

Affiliation

Wiernik PH; Our Lady of Mercy Cancer Center, New York Medical College, Bronx, NY, USA.

J Clin Oncol ; 26(30): 4952-7, 2008 Oct 20.

Article in En | MEDLINE | ID: mdl-18606983

Subject(s)

Lymphoma, Non-Hodgkin/drug therapy; Neoplasm Recurrence, Local/drug therapy; Thalidomide/analogs & derivatives; Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Agents/therapeutic use; Disease-Free Survival; Female; Hematologic Diseases/chemically induced; Humans; Lenalidomide; Lymphoma, Large B-Cell, Diffuse/drug therapy; Lymphoma, Mantle-Cell/drug therapy; Male; Middle Aged; Prospective Studies; Remission Induction; Thalidomide/adverse effects; Thalidomide/therapeutic use

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Thalidomide / Lymphoma, Non-Hodgkin / Neoplasm Recurrence, Local Type of study: Clinical_trials / Observational_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: J Clin Oncol Year: 2008 Type: Article Affiliation country: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google